News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Your AI-Trained Oncology Knowledge Connection!

BCMA as a Target in Heavily Pre-Treated RRMM

EP. 1: Treatment Approach for R/R Multiple Myeloma

BySagar Lonial, MD, FACP, Winship Cancer Institute of Emory University,Asim V. Farooq, MD, University of Chicago Medical Center,Natalie S. Callander, MD, University of Washington Carbone Cancer Center

December 18th 2020

EP. 2: The Rationale for Targeting BCMA in Multiple Myeloma

BySagar Lonial, MD, FACP, Winship Cancer Institute of Emory University,Asim V. Farooq, MD, University of Chicago Medical Center,Natalie S. Callander, MD, University of Washington Carbone Cancer Center

December 18th 2020

EP. 3: DREAMM-2 Trial Efficacy Data and Recent FDA Approval

BySagar Lonial, MD, FACP, Winship Cancer Institute of Emory University,Asim V. Farooq, MD, University of Chicago Medical Center,Natalie S. Callander, MD, University of Washington Carbone Cancer Center

January 18th 2021

EP. 4: DREAMM-2 Trial Regimen Safety Profile

BySagar Lonial, MD, FACP, Winship Cancer Institute of Emory University,Asim V. Farooq, MD, University of Chicago Medical Center,Natalie S. Callander, MD, University of Washington Carbone Cancer Center

January 18th 2021

EP. 5: Management of Ocular Events From DREAMM-2 Regimen

BySagar Lonial, MD, FACP, Winship Cancer Institute of Emory University,Asim V. Farooq, MD, University of Chicago Medical Center,Natalie S. Callander, MD, University of Washington Carbone Cancer Center

January 25th 2021

EP. 6: DREAMM-2 Trial Regimen: Safety Updates and Dose Delay

BySagar Lonial, MD, FACP, Winship Cancer Institute of Emory University,Asim V. Farooq, MD, University of Chicago Medical Center,Natalie S. Callander, MD, University of Washington Carbone Cancer Center

January 25th 2021

EP. 7: Next Steps for Use of Belantamab in Clinical Practice

BySagar Lonial, MD, FACP, Winship Cancer Institute of Emory University,Asim V. Farooq, MD, University of Chicago Medical Center,Natalie S. Callander, MD, University of Washington Carbone Cancer Center

February 1st 2021

EP. 8: Ongoing Approaches Toward Targeting BCMA

BySagar Lonial, MD, FACP, Winship Cancer Institute of Emory University,Asim V. Farooq, MD, University of Chicago Medical Center,Natalie S. Callander, MD, University of Washington Carbone Cancer Center

February 1st 2021

EP. 9: Influencing Factors to Initially Targeting BCMA in MM

BySagar Lonial, MD, FACP, Winship Cancer Institute of Emory University,Asim V. Farooq, MD, University of Chicago Medical Center,Natalie S. Callander, MD, University of Washington Carbone Cancer Center

February 1st 2021

Trending on OncLive

FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC

HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts

Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC

SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma

Five Under 5: Top Oncology Videos for the Week of 1/25